[HTML][HTML] Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment

MG Mazza, M Palladini, S Poletti, F Benedetti - CNS drugs, 2022 - Springer
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic is still spreading worldwide
over 2 years since its outbreak. The psychopathological implications in COVID-19 survivors …

[HTML][HTML] Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis

T Yang, MZ Yan, X Li, EHY Lau - Infection, 2022 - Springer
Objective Although complications and clinical symptoms of COVID-19 have been elucidated,
the prevalence of long-term sequelae of COVID-19 is less clear in previously hospitalized …

Neuropsychiatric aspects of long COVID: a comprehensive review

T Kubota, N Kuroda, D Sone - Psychiatry and Clinical …, 2023 - Wiley Online Library
Although some patients have persistent symptoms or develop new symptoms following
coronavirus disease 2019 (COVID‐19) infection, neuropsychiatric aspects of long COVID …

[HTML][HTML] Returning to work and the impact of post COVID-19 condition: A systematic review

MR Gualano, MF Rossi, I Borrelli, PE Santoro… - Work, 2022 - content.iospress.com
BACKGROUND: The COVID-19 pandemic is still ongoing, with rapidly increasing cases all
over the world, and the emerging issue of post COVID-19 (or Long COVID-19) condition is …

Global prevalence of post-COVID-19 sleep disturbances in adults at different follow-up time points: A systematic review and meta-analysis

TTD Linh, DKN Ho, NN Nguyen, CJ Hu, CH Yang… - Sleep Medicine …, 2023 - Elsevier
Our systematic review and meta-analysis estimated the prevalence of post-COVID sleep
disturbances in adult population. We systematically searched relevant studies from four …

[HTML][HTML] Long COVID, the brain, nerves, and cognitive function

AB Reiss, C Greene, C Dayaramani… - Neurology …, 2023 - mdpi.com
SARS-CoV-2, a single-stranded RNA coronavirus, causes an illness known as coronavirus
disease 2019 (COVID-19). Long-term complications are an increasing issue in patients who …

[HTML][HTML] Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia

M Tiger, R Wesselhoeft, P Karlsson, M Handal… - Journal of Affective …, 2023 - Elsevier
Objective To study patterns of antidepressant, anxiolytic, and hypnotic drug utilization in
Denmark, Norway, and Sweden during the first year of the COVID-19 pandemic. Methods …

[HTML][HTML] The global prevalence of depression, anxiety, and sleep disorder among patients coping with Post COVID-19 syndrome (long COVID): a systematic review …

N Seighali, A Abdollahi, A Shafiee, MJ Amini… - BMC psychiatry, 2024 - Springer
Background Post COVID-19 syndrome, also known as" Long COVID," is a complex and
multifaceted condition that affects individuals who have recovered from SARS-CoV-2 …

Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis

D Luo, B Mei, P Wang, X Li, X Chen, G Wei… - Clinical Microbiology …, 2023 - Elsevier
Background Long-term physical and mental persistent symptoms following COVID-19
represent a growing global public health concern. However, there remains a substantial …

Long-COVID stress symptoms: Mental health, anxiety, depression, or posttraumatic stress.

LY Saltzman, M Longo, TC Hansel - Psychological Trauma: Theory …, 2023 - psycnet.apa.org
Objective: Currently, there is no single profile of mental health sequela in long-coronavirus
disease (COVID) patients, impacting identification, treatment, and exacerbating stigma …